Meeting
2018 ASCO Annual Meeting
Timing of androgen deprivation therapy for prostate cancer patients after radiation: Planned combined analysis of two randomized phase 3 trials.
Authors
Andrew Loblaw
Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
Andrew Loblaw , Julie Bassett , Catherine D'Este , Gregory Russell Pond , Patrick Cheung , Jeremy Laurence Millar , Mark Frydenberg , Madeleine Trudy King , Himu Lukka , Shawn Malone , Roger L Milne , Tom Pickles , Rosemary Smith , Martin R. Stockler , Sandra Turner , Keen Hun Tai , Henry Woo , Gillian M. Duchesne
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Genitourinary (Prostate) Cancer
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Other Prostate, Testicular, or Penile Cancer
Citation
J Clin Oncol 36, 2018 (suppl; abstr 5018)
DOI
10.1200/JCO.2018.36.15_suppl.5018
Abstract #
5018
Poster Bd #
245
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
A phase III trial of short-term androgen deprivation therapy in intermediate-risk prostate cancer treated with radiotherapy.
First Author: Abdenour Nabid
Poster
2015 Genitourinary Cancers Symposium
Correlation between time to prostate cancer metastasis and overall survival after androgen deprivation therapy initiation.
First Author: Lillian Werner
Poster
2011 ASCO Annual Meeting
Phase III trial comparing long-term versus short-term androgen deprivation combined with high-dose radiotherapy for localized prostate cancer: GICOR protocol DART01/05.
First Author: A. Zapatero
Poster
2024 ASCO Genitourinary Cancers Symposium
Impact of exposure to clinical trials and standard-of-care therapy in metastatic or recurrent prostate cancer: An update.
First Author: Grace G Kim